参考文献/References:
[1]B?naa KH,Mannsverk J,Wiseth R,et al. Drug-eluting or bare-metal stents for coronary artery disease[J]. N Engl J Med,2016,375(13):1242-1252.?
[2]Shlofmitz E,Iantorno M,Waksman R. Restenosis of drug-eluting stents:a new classification system based on disease mechanism to guide treatment and state-of-the-art review[J]. Circ Cardiovasc Interv,2019,12(8):e007023.
[3]Mintz GS,Guagliumi G. Intravascular imaging in coronary artery disease[J]. Lancet,2017,390(10096):793-809.
[4]Mintz GS,Nissen SE,Anderson WD,et al. American College of Cardiology Clinical Expert Consensus Document on Standards for Acquisition, Measurement and Reporting of Intravascular Ultrasound Studies (IVUS).A report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents[J]. J Am Coll Cardiol,2001,37(5):1478-1492.
[5]Hong SJ,Kim BK,Shin DH,et al. Usefulness of intravascular ultrasound guidance in percutaneous coronary intervention with second-generation drug-eluting stents for chronic total occlusions (from the Multicenter Korean-Chronic Total Occlusion Registry) [J]. Am J Cardiol,2014,114(4):534-540.
[6]Tian NL,Gami SK,Ye F,et al. Angiographic and clinical comparisons of intravascular ultrasound-versus angiography-guided drug-eluting stent implantation for patients with chronic total occlusion lesions:two-year results from a randomised AIR-CTO study[J]. EuroIntervention,2015,10(12):1409-1417.
[7]Kim BK,Shin DH,Hong MK, et al. Clinical impact of intravascular ultrasound-guided chronic total occlusion intervention with zotarolimus-eluting versus biolimus-eluting stent implantation:randomized study[J]. Circ Cardiovasc Interv,2015,8(7):e002592.
[8]Shin DH,Hong SJ,Mintz GS,et al. Effects of intravascular ultrasound-guided versus angiography-guided new-generation drug-eluting stent implantation:meta-analysis with individual patient-level data from 2 345 randomized patients[J]. JACC Cardiovasc Interv,2016,9(21):2232-2239.
[9]Malik AH,Yandrapalli S,Aronow WS,et al. Intravascular ultrasound-guided stent implantation reduces cardiovascular mortality—Updated meta-analysis of randomized controlled trials[J]. Int J Cardiol,2020,299:100-105.
[10]中华医学会心血管病学分会介入心脏病学组,中国医师协会心血管内科医师分会血栓防治专业委员会,中华心血管病杂志编辑委员会,等. 中国经皮冠状动脉介入治疗指南(2016)[J]. 中华心血管病杂志,2016,44(5):382-400.
[11]De la Torre Hernandez JM,Alfonso F,Sanchez Recalde A,et al. Comparison of paclitaxel-eluting stents(Taxus) and everolimus-eluting stents(Xience) in left main coronary artery disease with 3 years follow-up(from the ESTROFA-LM registry) [J]. Am J Cardiol,2013,111(5):676-683.
[12]Tan Q,Wang Q,Liu D,et al. Intravascular ultrasound-guided unprotected left main coronary artery stenting in the elderly[J]. Saudi Med J,2015,36(5):549-553.
[13]Tian J,Guan C,Wang W,et al. Intravascular ultrasound guidance improves the long-term prognosis in patients with unprotected left main coronary artery disease undergoing percutaneous coronary intervention[J]. Sci Rep,2017,7(1):2377.
[14]Andell P,Karlsson S,Mohammad MA,et al. Intravascular ultrasound guidance is associated with better outcome in patients undergoing unprotected left main coronary artery stenting compared with angiography guidance alone[J]. Circ Cardiovasc Interv,2017,10(5):e004813.
[15]Liu XM,Yang ZM,Liu XK,et al. Intravascular ultrasound-guided drug-eluting stent implantation for patients with unprotected left main coronary artery lesions:a single-center randomized trial[J]. Anatol J Cardiol,2019,21(2):83-90.
[16]Ye Y,Yang M,Zhang S,et al. Percutaneous coronary intervention in left main coronary artery disease with or without intravascular ultrasound:a meta-analysis[J]. PLoS One,2017,12(6):e0179756.
[17]Wang Y,Mintz GS,Gu Z,et al. Meta-analysis and systematic review of intravascular ultrasound versus angiography-guided drug eluting stent implantation in left main coronary disease in 4 592 patients[J]. BMC Cardiovasc Disord,2018,18(1):115.
[18]Neumann FJ,Sousa-Uva M,Ahlsson A,et al. 2018 ESC/EACTS Guidelines on myocardial revascularization[J]. Eur Heart J,2019,40(2):87-165.
[19]Kim SH,Kim YH,Kang SJ,et al. Long-term outcomes of intravascular ultrasound-guided stenting in coronary bifurcation lesions[J]. Am J Cardiol, 2010,106(5):612-618.
[20]Kim JS,Hong MK,Ko YG,et al. Impact of intravascular ultrasound guidance on long-term clinical outcomes in patients treated with drug-eluting stent for bifurcation lesions:data from a Korean multicenter bifurcation registry[J]. Am Heart J,2011,161(1):180-187.
[21]Chen L,Xu T,Xue XJ,et al. Intravascular ultrasound-guided drug-eluting stent implantation is associated with improved clinical outcomes in patients with unstable angina and complex coronary artery true bifurcation lesions[J]. Int J Cardiovasc Imaging,2018,34(11):1685-1696.
[22]Choi KH,Song YB,Lee JM,et al. Impact of intravascular ultrasound-guided percutaneous coronary intervention on long-term clinical outcomes in patients undergoing complex procedures[J]. JACC Cardiovasc Interv,2019,12(7):607-620.
[23]Kim JS,Kang TS,Mintz GS,et al. Randomized comparison of clinical outcomes between intravascular ultrasound and angiography-guided drug-eluting stent implantation for long coronary artery stenoses[J]. JACC Cardiovasc Interv,2013,6(4):369-376.
[24]Hong SJ,Kim BK,Shin DH,et al. Effect of intravascular ultrasound-guided vs angiography-guided everolimus-eluting stent implantation:the IVUS-XPL randomized clinical trial[J]. JAMA,2015,314(20):2155-2163.
[25]Hong SJ,Mintz GS,Ahn CM,et al. Effect of intravascular ultrasound-guided drug-eluting stent implantation:5-year follow-up of the IVUS-XPL randomized trial[J]. JACC Cardiovasc Interv,2020,13(1):62-71.
[26]王伟民,霍勇,葛均波. 冠状动脉钙化病变诊治中国专家共识[J]. 中国介入心脏病学杂志,2014,22(2):69-73.
[27]Huisman J,van der Heijden LC,Kok MM,et al. Impact of severe lesion calcification on clinical outcome of patients with stable angina,treated with newer generation permanent polymer-coated drug-eluting stents:a patient-level pooled analysis from TWENTE and DUTCH PEERS (TWENTE Ⅱ)[J]. Am Heart J,2016,175:121-129.
[28]Mintz GS,Popma JJ,Pichard AD,et al. Patterns of calcification in coronary artery disease.A statistical analysis of intravascular ultrasound and coronary angiography in 1 155 lesions[J]. Circulation,1995,91(7):1959-1965.
[29]Mintz GS,Nissen SE,Anderson WD,et al. American College of Cardiology Clinical Expert Consensus Document on Standards for Acquisition,Measurement and Reporting of Intravascular Ultrasound Studies (IVUS).A report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents[J]. J Am Coll Cardiol,2001,37(5):1478-1492.
[30]孙勇,蒋峻,朱国忠,等. 血管内超声指导下冠状动脉严重钙化病变旋磨治疗的有效性[J]. 中华心血管病杂志,2014,42(7):545-550.
[31]Jakabcin J,Spacek R,Bystron M,et al. Long-term health outcome and mortality evaluation after invasive coronary treatment using drug eluting stents with or without the IVUS guidance.Randomized control trial.HOME DES IVUS[J]. Catheter Cardiovasc Interv,2010,75(4):578-583.
[32]Chieffo A,Latib A,Caussin C,et al. A prospective,randomized trial of intravascular-ultrasound guided compared to angiography guided stent implantation in complex coronary lesions:the AVIO trial[J]. Am Heart J,2013,165(1):65-72.
[33]Shlofmitz E,Torguson R,Zhang C,et al. Impact of Intravascular Ultrasound on Outcomes Following PErcutaneous Coronary InterventioN in Complex Lesions (iOPEN Complex)[J]. Am Heart J,2020,221:74-83.
[34]Fan Z,Xu M,Xiao Y,et al. Intravascular ultrasound versus angiography-guided drug-eluting stent implantation in patients with complex coronary lesions:an updated meta-analysis of nine randomized clinical trials[J]. Anatol J Cardiol, 2019,22(4):160-167.
[35]Zhang J,Gao X,Kan J,et al. Intravascular ultrasound versus angiography-guided drug-eluting stent implantation:the ultimate trial[J]. J Am Coll Cardiol, 2018,72(24):3126-3137.
相似文献/References:
[1]刘凡 杨树森.血流储备分数指导冠状动脉再血管化的相关进展[J].心血管病学进展,2019,(5):797.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.033]
LIU FanYANG Shusen.The Relevant Grogress of FFR-Guided Coronary Revascularization[J].Advances in Cardiovascular Diseases,2019,(11):797.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.033]
[2]黄爽 吉维 楚天舒.血管内超声应用于 冠状动脉介入治疗中最新研究进展[J].心血管病学进展,2020,(11):1137.[doi:10.16806/j.cnki.issn.1004-3934.2020.11.000]
HUANG Shuang,JI Wei,CHU Tianshu.Application of Intravascular Ultrasound in Coronary Interventional Therapy[J].Advances in Cardiovascular Diseases,2020,(11):1137.[doi:10.16806/j.cnki.issn.1004-3934.2020.11.000]
[3]马越 宋雷 乔树宾.腔内影像学在冠状动脉支架内再狭窄中应用的研究进展[J].心血管病学进展,2021,(3):202.[doi:10.16806/j.cnki.issn.1004-3934.20.03.003]
MA Yue,SONG Lei,QIAO Shubin.Application of Intravascular Imaging in Coronary Artery In-stent Restenosis[J].Advances in Cardiovascular Diseases,2021,(11):202.[doi:10.16806/j.cnki.issn.1004-3934.20.03.003]
[4]陈忠秀 李娅姣 李春梅 李晨.无导丝虚拟血流储备分数技术在稳定性冠心病介入治疗中的指导价值[J].心血管病学进展,2022,(10):865.[doi:10.16806/j.cnki.issn.1004-3934.2022.10.001]
CHEN Zhongxiu,LI Yajiao,LI Chunmei,et al.The Value of Wireless Virtual Fractional Flow Reserve in Guiding Percutaneous Coronary Intervention in Stable Coronary Artery Disease[J].Advances in Cardiovascular Diseases,2022,(11):865.[doi:10.16806/j.cnki.issn.1004-3934.2022.10.001]
[5]刘春伟 胡越成 张敬霞 王林 丛洪良.从腔内影像学进展探讨冠状动脉易损斑块的临床意义[J].心血管病学进展,2022,(10):877.[doi:10.16806/j.cnki.issn.1004-3934.2022.10.004]
LIU Chunwei,HU Yuecheng,ZHANG Jingxia,et al.The Vulnerable Plaque:Intracoronary Imaging and Clinical Value[J].Advances in Cardiovascular Diseases,2022,(11):877.[doi:10.16806/j.cnki.issn.1004-3934.2022.10.004]
[6]林子健 许俊炜 陈剑 陈柏荣 罗礼云.血管内超声衰减斑块的研究进展[J].心血管病学进展,2023,(4):312.[doi:10.16806/j.cnki.issn.1004-3934.2023.04.006]
LIN Zijian,XU Junwei,CHEN Jian,et al.Attenuated Plaque Identified by Intravascular Ultrasound[J].Advances in Cardiovascular Diseases,2023,(11):312.[doi:10.16806/j.cnki.issn.1004-3934.2023.04.006]
[7]谢飞 周芃 张冠龙.心绞痛患者病变血管斑块的血管内超声特征参数变化及其临床意义[J].心血管病学进展,2023,(4):376.[doi:10.16806/j.cnki.issn.1004-3934.2023.04.019]
IE Fei,ZHOU Peng,ZHANG Guanlong (Department of Cardiovascular Medicine,et al.Analysis of Coronary Plaque Unstability by Intravascular Ultrasound Parameters in Angina Patients XIE Fei, ZHOU Peng, ZHANG Guanlong (Department of Cardiovascular Medicine,The?7th?People’s?Hospital?of?ZhengZhou,Zhengzhou 450000,Henan,China)[J].Advances in Cardiovascular Diseases,2023,(11):376.[doi:10.16806/j.cnki.issn.1004-3934.2023.04.019]